Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at PM01183 for pancreatic cancer

Overview

Cancer types:

Pancreatic cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at a new drug PM01183 to treat pancreatic cancer that has spread to other parts of the body.

Pancreatic cancer that has spread to other parts of the body is sometimes called advanced pancreatic cancer. Doctors usually treat this with chemotherapy including the drug gemcitabine. Sadly this doesn’t always work very well so doctors want to find new drugs to help people with advanced pancreatic cancer.

PM01183 is a new drug that affects how cancer cells divide and grow. Researchers want to find out if it can help people with advanced pancreatic cancer.

The aim of this trial is to find out

  • If PM01183 can help people with advanced pancreatic cancer that has come back or did not go away with chemotherapy

  • About the side effects

Recruitment start: 1 January 2012

Recruitment end: 4 December 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr David Cunningham

Supported by

Pharma Mar

Last reviewed: 23 November 2015

CRUK internal database number: 9640

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.